Adjunctive imipramine for a broader group of post-psychotic depressions in schizophrenia

Schizophrenia Research

Volumn 44, Issue 3, 2000, Pages 187-192

  Siris, Samuel ^a,b   Pollack, Simcha ^c   Bermanzohn, Paul ^a,b   Stronger, Roslyn ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

Adjunctive medication strategy; Antidepressant medication; Neuroleptic medication; Post psychotic depression; Schizophrenia

Indexed keywords

BENZATROPINE; FLUPHENAZINE DECANOATE; IMIPRAMINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL PRACTICE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; TREATMENT PLANNING;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; BENZTROPINE; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLUPHENAZINE; HUMANS; IMIPRAMINE; MALE; MUSCARINIC ANTAGONISTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034284033     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00197-8     Document Type: Article

References (25)

1. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1994;American Psychiatric Press, Washington, DC.
2. Bermanzohn P.C., Siris S.G. Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms. Comp. Psychiatry. 33:1992;221-232.
3. Birchwood M., Mason R., Macmillan F., Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol. Med. 23:1993;387-395.
4. Caldwell C.B., Gottesman I.I. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr. Bull. 16:1990;571-589.
5. Drake R.E., Cotton P.G. Depression, hopelessness and suicide in chronic schizophrenia. Br. J. Psychiatry. 148:1986;554-559.
6. Endicott J., Cohen J., Nee J., Fleiss J., Sarantakos S. Hamilton Depression Rating Scale: extracted from regular and change versions of the Schedule for Affective Disorders and Schizophenia. Arch. Gen. Psychiatry. 38:1981;98-103.
7. Endicott J., Spitzer R.L. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry. 35:1978;837-844.
8. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry. 33:1976;766-771.
9. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. 1976;National Institute of Mental Health, Rockville, MD. DHEW Publication No. 76-336.
10. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
11. Heila H., Isometsa E.T., Henriksson M.M., Heikkinen M.E., Marttunen M.J., Lonnqvist J.K. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry. 154:1997;1235-1242.
12. Johnson D.A.W. The significance of depression in the prediction of relapse in chronic schizophrenia. Br. J. Psychiatry. 152:1988;320-323.
13. Kramer M.S., Vogel W.H., DiJohnson C., Dewey D.A., Sheves P., Cavicchia S., Litle P., Schmidt R., Kimes I. Antidepressants in 'depressed' schizophrenic inpatients: a controlled trial. Arch. Gen. Psychiatry. 46:1989;922-928.
14. Plasky P. Antidepressant usage in schizophrenia. Schizophr. Bull. 17:1991;75-98.
15. Rifkin A., Quitkin F., Klein D.F. Akinesia: a poorly recognized drug-induced extrapyramidal behavioral disorder. Arch. Gen. Psychiatry. 32:1975;672-674.
16. Roy A., Thompson R., Kennedy S. Depression in chronic schizophrenia. Br. J. Psychiatry. 142:1983;465-470.
17. Siris S.G. Akinesia and post-psychotic depression: a difficult differential diagnosis. J. Clin. Psychiatry. 48:1987;240-243.
18. Siris S.G. Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. Schizophr. Bull. 17:1991;75-98.
19. Siris S.G. Depression and schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;128-145 Blackwell Science, Cambridge, MA.
20. Siris, S.G. Depression in the course of schizophrenia. In: Hwang, M.Y., Bermanzohn, P.C., Management of Schizophrenia with Comorbid Conditions. American Psychiatric Press, Washington DC, in press.
21. Siris, S.G., Addington, D., Azorin, J.M., Falloon, I.R.H., Gerlach, J., Hirsch, S.R., 1999. Depression in schizophrenia: recognition and management in the USA. Presented at the 7th International Congress on Schizophrenia Research, 17-21 April, Santa Fe, NM.
22. Siris S.G., Bermanzohn P.C., Mason S.E., Shuwall M.A. Maintenance imipramine therapy for secondary depression in schizophrenia: a controlled trial. Arch. Gen. Psychiatry. 51:1994;109-115.
23. Siris S.G., Morgan V., Fagerstrom R., Rifkin A., Cooper T.B. Adjunctive imipramine in the treatment of post-psychotic depression: a controlled trial. Arch. Gen. Psychiatry. 44:1987;533-539.
24. Spitzer R.L., Endicott J., Robins E. Research Diagnostic Criteria: rationale and reliability. Arch. Gen. Psychiatry. 35:1978;773-782.
25. Van Putten T., May P.R.A. 'Akinetic depression' in schizophrenia. Arch. Gen. Psychiatry. 35:1978;1101-1107.